Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125026192 | 12502619 | 2 | F | 20160706 | 20160627 | 20160715 | EXP | PHHY2016AU085234 | SANDOZ | 0.00 | M | Y | 108.00000 | KG | 20160715 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125026192 | 12502619 | 1 | PS | METOPROLOL. | METOPROLOL | 1 | Unknown | 12.5 MG, UNK | U | 73288 | 12.5 | MG | |||||||
| 125026192 | 12502619 | 2 | SS | METOPROLOL. | METOPROLOL | 1 | U | 73288 | |||||||||||
| 125026192 | 12502619 | 3 | SS | GALVUMET | METFORMIN HYDROCHLORIDEVILDAGLIPTIN | 1 | Unknown | U | 0 | ||||||||||
| 125026192 | 12502619 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 120 MG, QD (IN MORNING) | U | 0 | 120 | MG | QD | ||||||
| 125026192 | 12502619 | 5 | C | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD, AT NIGHT | U | 0 | 60 | MG | QD | ||||||
| 125026192 | 12502619 | 6 | C | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125026192 | 12502619 | 7 | C | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125026192 | 12502619 | 8 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | 300 MG, QD, AT NIGHT | U | 0 | 300 | MG | QD | ||||||
| 125026192 | 12502619 | 9 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | U | 0 | |||||||||||
| 125026192 | 12502619 | 10 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | U | 0 | |||||||||||
| 125026192 | 12502619 | 11 | C | EPILIM | VALPROATE SODIUM | 1 | Unknown | 400 MG, BID | U | 0 | 400 | MG | BID | ||||||
| 125026192 | 12502619 | 12 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | 20 MG, QD, NIGHT | U | 0 | 20 | MG | QD | ||||||
| 125026192 | 12502619 | 13 | C | EUTROXSIG | LEVOTHYROXINE SODIUM | 1 | Unknown | 50 UG, QD, MORNING | U | 0 | 50 | UG | QD | ||||||
| 125026192 | 12502619 | 14 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 1 DF, BID | U | 0 | 1 | DF | INHALER | BID | |||||
| 125026192 | 12502619 | 15 | C | NEXIUM I.V. | ESOMEPRAZOLE SODIUM | 1 | Unknown | 20 MG, QD (MORNING) | U | 0 | 20 | MG | QD | ||||||
| 125026192 | 12502619 | 16 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 100 MG, QD, IN MORNING | U | 0 | 100 | MG | QD | ||||||
| 125026192 | 12502619 | 17 | C | CENTRUM | VITAMINS | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 125026192 | 12502619 | 18 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | 1000 IU, QD, IN MORNING | U | 0 | 1000 | IU | QD | ||||||
| 125026192 | 12502619 | 19 | C | COD LIVER OIL | COD LIVER OIL | 1 | Unknown | 1000 MG, QD, IN MORNING | U | 0 | 1000 | MG | QD | ||||||
| 125026192 | 12502619 | 20 | C | PANADOL | ACETAMINOPHEN | 1 | Unknown | 1330 MG, BID | U | 0 | 1330 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125026192 | 12502619 | 1 | Cardiac disorder |
| 125026192 | 12502619 | 2 | Hypertension |
| 125026192 | 12502619 | 3 | Product used for unknown indication |
| 125026192 | 12502619 | 4 | Depression |
| 125026192 | 12502619 | 5 | Delusion |
| 125026192 | 12502619 | 6 | Hallucination |
| 125026192 | 12502619 | 7 | Depression |
| 125026192 | 12502619 | 8 | Delusion |
| 125026192 | 12502619 | 9 | Hallucination |
| 125026192 | 12502619 | 10 | Depression |
| 125026192 | 12502619 | 11 | Affective disorder |
| 125026192 | 12502619 | 12 | Blood cholesterol increased |
| 125026192 | 12502619 | 13 | Hypothyroidism |
| 125026192 | 12502619 | 14 | Chronic obstructive pulmonary disease |
| 125026192 | 12502619 | 15 | Gastrooesophageal reflux disease |
| 125026192 | 12502619 | 16 | Product used for unknown indication |
| 125026192 | 12502619 | 17 | Product used for unknown indication |
| 125026192 | 12502619 | 18 | Product used for unknown indication |
| 125026192 | 12502619 | 19 | Product used for unknown indication |
| 125026192 | 12502619 | 20 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125026192 | 12502619 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125026192 | 12502619 | Acute coronary syndrome | |
| 125026192 | 12502619 | Asthenia | |
| 125026192 | 12502619 | Blood pressure increased | |
| 125026192 | 12502619 | Chest pain | |
| 125026192 | 12502619 | Cognitive disorder | |
| 125026192 | 12502619 | Coronary artery disease | |
| 125026192 | 12502619 | Coronary artery stenosis | |
| 125026192 | 12502619 | Dyspnoea | |
| 125026192 | 12502619 | Emphysema | |
| 125026192 | 12502619 | Osteoarthritis | |
| 125026192 | 12502619 | Schizophrenia | |
| 125026192 | 12502619 | Sleep apnoea syndrome | |
| 125026192 | 12502619 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |